Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by trade2win2on Jun 14, 2012 1:32pm
392 Views
Post# 20014388

RE: Disgusted!

RE: Disgusted!

Just wanted to thank this great management team for a job well done!!! not!, in the last few weeks they have taken our shares, approved a new option plan for themselves and then stood by and watched the share price fall. its my opinion that the only reason they rushed this consolidation through was because they knew  the share price would not hold the 3 cent range... if they were doing it for us, the share holders and to attract new investors they would of worked to get the price up over 10 cents and then consolidated the shares to put the price up over a buck allowing more institutional investors to purchase.I believe we will fall to the 20 cent range or below which in their eyes is a lot better than 1 cent or less, which it would of been before consolidation. this was the reason for rushing the consolidation.   A few days ago a person posted telling us to talk to a PROFESSIONAL about the consolidation and what it means for the company.. I wonder if he feels the same right now... I have been through two of these before, the difference was both companies did them with higher share prices and then was able to move the stock from the V to the TSX... NICE JOB GUYS..   Stuck in the mud with this one...          

Bullboard Posts